Novartis veteran appointed EFPIA's interim director general as Richard Bergström leaves

12 December 2016

A new man is at the helm of the European Federation of Pharmaceutical Industries and Association (EFPIA) after the departure of Richard Bergström – albeit on an interim basis.

Eric Cornut becomes the interim director general, succeeding Mr Bergström, who spent five years as the head of the trade group, during which time he has been credited for giving strong leadership through a period of dynamic change.

"2017 will be a critical year for the industry, with major milestones including the reviews of key legislations and the commission’s roadmap on HTA co-operation in Europe"

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK